Gallery front |
Photos |
A nurse uses a syringe to draw Lenacapavir, an antiretroviral HIV prevention drug from a vial during a roll out of the drug as part of an implementation study by a Wits University research unit.
A nurse uses a syringe to draw Lenacapavir, an antiretroviral HIV prevention drug from a vial during a roll out of the drug as part of an implementation study by a Wits University research unit.
A nurse uses a syringe to draw Lenacapavir, an antiretroviral HIV prevention drug from a vial during a roll out of the drug as part of an implementation study by a Wits University research unit.
